The AKT pathway is widely acknowledged as a critical regulator of tumour progression.14 To determine whether the behaviours of UM‐SCC6‐M cells were due to the up‐regulation of pAKT, cells were treated with the AKT inhibitor, MK‐2206. Here, AKT1 is linked to neoplasm.